Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

TB-SPECTRUM A step forward for unraveling the immune mechanisms and tools for tuberculosis spectrum management

Coordinator
Institut De Investigacio En Ciencies De La Salut Germans Trias I Pujol, Spain
Runs
1 January 2026 to 31 December 2029
Status
Running
EU funding
€897k
Total cost
—
Partners
9 organisations in 8 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101236673

What the project is doing

In the project's own words, from its summary on CORDIS.

TB-SPECTRUM aims to strengthen international research collaboration among different sectors and disciplines, and to structure a network to perform high-quality, translational, and multidisciplinary research for (i) a better understanding of tuberculosis (TB) spectrum immune mechanisms; and (ii) increasing the capacities of the involved staff fostering training and networking activities, as well as increasing their inter-sectoral employability opportunities.

Understanding the host-pathogen interactions in the different phases of the spectrum is fundamental for detecting biomarkers of disease progression that can lead to new diagnostic approaches for identifying those individuals with a high-risk of developing disease if infected or for detecting subclinical TB forms. However, it is still unknown which immunological mechanisms are involved in infection/disease progression.

To unravel this knowledge gap, it is mandatory to develop collaborative research which combines different expertise in the TB field (clinics, diagnostics, treatment, clinical studies management, cellular/humoral immunology, genomics, and technology transfer, among others). For that purpose, a Consortium of nine academic and non-academic Institutions harboring TB-renowned experts has been constituted. This network is formed by specialists in the clinical management of active TB cases and their contacts (from high and low incident countries); experts in basic/applied science; and a small and medium-sized enterprise (SME) involved in the development of immune assays.

Altogether, the proposed goals will be achieved through secondments among the different sectors, which will be extremely important for progressing to a better understanding of the requirements needed in TB management and control; and will expose participants to new research environments that will reinforce multidisciplinarity. Moreover, the interaction with an SME will improve knowledge transference skills, stimulating entrepreneurship.

Topics

Who is involved

OrganisationCityCountryRole
Institut De Investigacio En Ciencies De La Salut Germans Trias I PujolBadalona BarcelonaSpainCoordinator
Genome Identification Diagnostics GmbHStrassbergGermanyParticipant
Servicios Clinicos SABarcelonaSpainParticipant
Institutia Medico-Sanitara Publica - Institutul De Pneumologie ""chiril Draganiuc""""ChisinauMoldovaParticipant
Bingham UniversityKaruNGAssociatedpartner
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant
I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do PortoPortoPortugalParticipant
Institutul De Pneumoftiziologie Marius NastaBucurestiRomaniaParticipant
The University of Texas SystemAustinUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI